PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.\', \'Institute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.\', \'Laboratory for Protein Synthesis and Expression, Institute for Protein Research, Osaka University, Osaka, Japan.\', \'Department of Nephrology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.\', \'Department of Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.\', \'Department of Infection Metagenomics, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.\', \'Department of Veterinary Pathology, Yamaguchi University, Yamaguchi, Japan.\', \'The Core Instrumentation Facility, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.\', \'Department of Molecular Virology, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.\', \'Institute for Advanced Co-Creation Studies, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan. toru@biken.osaka-u.ac.jp.\', \'Laboratory for Protein Synthesis and Expression, Institute for Protein Research, Osaka University, Osaka, Japan. takagi@protein.osaka-u.ac.jp.\', \'Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. a-hoshi@koto.kpu-m.ac.jp.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-021-24013-y
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 34155214
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all